United States: CMS Issues Final Mandatory Episode Payment Models For Cardiac And Orthopedic Cases, Plus New Cardiac Rehabilitation Incentive Payment Model And CJR Program Refinements

In the waning days of the Obama Administration, the Centers for Medicare & Medicaid Services (CMS) has unveiled a lengthy and complex final rule to establish mandatory Medicare bundled payment programs for acute myocardial infarction (AMI), coronary artery bypass graft (CABG), and surgical hip/femur fracture treatment (SHFFT) procedures furnished in designated geographic areas. The rule also includes provisions to promote the use of cardiac rehabilitation services, refine current Comprehensive Care for Joint Replacement Model (CJR) rules, and integrate bundled payment programs into the new physician Quality Payment Program. The 1,606-page advance version of the rule was released on December 20, 2016; the official version is scheduled to be published January 3, 2017.

Note that President-elect Donald Trump's designee for Secretary of Health and Human Services, Rep. Tom Price, M.D., has been highly critical of the proposed version of the rule published in August 2016, and has called on the CMS Center for Medicare and Medicaid Innovation (CMMI) to "stop experimenting with Americans' health, and cease all current and future planned mandatory initiatives within the CMMI." It is therefore uncertain whether all provisions of the final rule will actually be implemented as CMS currently envisions. Nevertheless, impacted providers need to be prepared for potentially significant changes.

Mandatory Episode Payment Models for Cardiac Care, Hip/Femur Fractures

The final rule establishes new "episode payment models" (EPMs) that seek to "advance CMS' goal of improving the efficiency and quality of care for Medicare beneficiaries and encourage hospitals, physicians, and post-acute care providers to work together to improve the coordination of care from the initial hospitalization through recovery." CMS estimates that the EPMs will save $159 million during the duration of the program (July 1, 2017 through December 31, 2021).

CMS will "test" the EPMs beginning July 1, 2017 and ending December 31, 2021. CMS has selected 98 metropolitan statistical areas (MSAs) for the CABG and AMI EPMs, and will implement the SHFFT model in the same 67 MSAs where the CJR program is already underway. Acute care hospitals in these areas will participate in the models if they are paid under the Inpatient Prospective Payment System (IPPS) and are not concurrently participating in Models 2, 3, or 4 of the Innovation Center's Bundled Payment for Care Improvement (BPCI) initiative for AMI, CABG, or SHFFT episodes. CMS estimates that approximately 1,120 hospitals will participate in the AMI and CABG models, and 860 hospitals will participate in the SHFFT model.

Under the final rule, an AMI, CABG, or SHFFT model episode will begin with an inpatient admission to an "anchor hospital" for the following specified Medicare Severity-Diagnosis Related Groups (MS-DRG):

AMI Model: AMI MS-DRGs 280-282 and those Percutaneous Coronary Intervention (PCI) MS-DRGs (246-251) with an ICD-10-CM diagnosis code of AMI

CABG Model: MS-DRGs 231-236

SHFFT Model: MS-DRGs 480-482

The episode will end 90 days after the date of discharge. The episode will include the inpatient stay and almost all related care covered under Medicare Parts A and B within the 90 days after discharge, including hospital care, post-acute care, and physician services, with very limited exceptions. Note, however, that CMS will continue to pay hospitals and other providers and suppliers according to the usual Medicare fee-for-service (FFS) rules.

As under the current CJR program, the acute care hospital will be the "episode initiator" and bear financial risk for the quality and cost of EPM care. At the completion of an EPM model performance year (PY), CMS will compare (1) actual Medicare claims data for Medicare Parts A and B services furnished to beneficiaries during the episode, to (2) a hospital's quality-adjusted target price based on historical data with various adjustments and discount factors to reflect savings to Medicare. The target price initially will be based on a blend of hospital-specific and regional historical data, gradually transitioning to only regional pricing. Hospitals that deliver care for less than the quality-adjusted target price and meet applicable quality standards will be eligible for a "reconciliation payment"; hospitals with costs that exceed the quality-adjusted target price will be required to repay Medicare after a phase-in period.

A number of factors are considered in determining reconciliation and repayment amounts, including stop-loss and stop-gain limits intended to "both protect hospitals from excess financial risk offset while limiting gains proportional to the potential downside risk."

The final stop-gain limits are as follows:

PY Calendar Year EPM Episodes Included Stop Gain Limit
1 2017 EPM episodes that start on or after July 1, 2017 and end on or before December 31, 2017 Up to 5% of quality-adjusted target price
2 2018 EPM episodes that end between January 1, 2018 and December 31, 2018, inclusive Up to 5% of quality-adjusted target price
3 2019 EPM episodes that end between January 1, 2019 and December 31, 2019, inclusive Up to 5% of quality-adjusted target price
4 2020 EPM episodes that end between January 1, 2020 and December 31, 2020, inclusive Up to 10% of quality-adjusted target price
5 2021 EPM episodes that end between January 1, 2021 and December 31, 2021, inclusive Up to 20% of quality-adjusted target price

In the final rule, CMS is delaying the requirement to assume downside risk by 9 months; episodes ending on or after January 1, 2019 must assume downside risk. CMS is, however, allowing participants to voluntarily elect downside risk for episodes ending on or after January 1, 2018 in order to qualify as an Advanced Alternative Payment Model (APM) under the separate CMS Quality Payment Program (assuming all other conditions are met). The following table summarizes the final stop-loss thresholds and discount percentages by performance year (with lower thresholds for certain rural hospitals):

PY 1 PY 2 PY 3 PY 4 PY 5
Downside Risk (DR) for All Participants– DR effective for episodes ending on or after 1/1/2019 (anchor discharges occurring on or after 10/4/2018)
Stop-loss threshold n/a as no downside risk in PY1 and PY2 without election of voluntary downside risk for PY2 5% 10% 20%
Stop loss threshold for certain hospitals* 3% 5% 5%
Discount percentage (range) for Repayment, Depending on Quality Category 0.5%-2.0% 0.5%-2.0% 1.5%-3.0%
Voluntary Downside Risk – DR effective for episodes ending on or after 1/1/2018 (anchor discharges occurring on or after 10/4/2017)
Stop-loss threshold n/a as no downside risk in PY1 5% 5% 10% 20%
Stop loss threshold for certain hospitals* 3% 3% 5% 5%
Discount percentage (range) for Repayment, Depending on Quality Category 0.5%-2.0% 0.5%-2.0% 0.5%-2.0% 1.5%-3.0%

*Including rural and sole-community hospitals, rural referral centers, Medicare Dependent Hospitals and hospitals determined to be EPM volume protection hospitals within an EPM.

CMS anticipates that EPM hospitals will enter into financial arrangements that allow EPM participants to share financial risk with EPM "collaborators" (e.g., gainsharing). The final rule includes the following entities as permissible EPM collaborators: accountable care organizations; skilled nursing facilities (SNFs); home health agencies; long-term care hospitals; inpatient rehabilitation facilities; physicians; nonphysician practitioners; therapists in private practice; comprehensive outpatient rehabilitation facilities; providers of outpatient therapy services; physician group practices; hospitals; critical access hospitals; non-physician practitioner group practices, and therapy group practices. Any such financial arrangements must meet extensive standards set forth in the rule.

Under the final rule, CMS is waiving certain current Medicare rules to promote flexibility, including the three-day inpatient hospital stay requirement prior to a covered SNF stay (in limited circumstances) and certain telehealth restrictions. CMS is not waiving fraud and abuse authorities under the final rule, but CMS states that the HHS Office of the Inspector General (OIG) and CMS will jointly issue waivers of certain fraud and abuse laws for purposes of testing these models.

Cardiac Rehabilitation Model

CMS is also finalizing a new Cardiac Rehabilitation (CR) incentive payment model to test the use of CR and intensive cardiac rehabilitation (ICR) services for beneficiaries hospitalized for treatment of an AMI or CABG for 90 days post-hospital discharge, where the beneficiary's overall care is paid under either an EPM or the Medicare FFS program. CR incentive payments will be available to hospital participants in 45 geographic areas that were selected for the CABG and AMI EPMs and 45 geographic areas that were not selected for the EPM program, and it will cover the same period as the cardiac care EPMs.

Under this model, CMS will make standard Medicare payments to providers for CR/ICR services (HCPCS codes 93797, 93798, G0422, and G0423), with an additional retrospective payment to participant hospitals based on total CR service use by beneficiaries attributed to the hospital (subject to Medicare coverage limits). CMS will make an initial payment of $25 per CR/ICR service for each of the first 11 CR/ICR services paid for by Medicare during the care period; after 11 services, the per-service payment increases to $175.

CMS estimates that 1,320 hospitals will participate in the CR Incentive Payment Model, and that the model's impact on Medicare spending could range between $29 million in net Medicare costs and $32 million in net Medicare savings from July 2017 through December 2024, depending on the change in utilization of CR/ICR services.

Changes to CJR Program

The final rule adopts numerous changes to CJR program rules, including modifications to promote consistency with other EPM policies. Among many other things, the final rule: modifies the calculation of quality adjusted target prices for Performance Years 3, 4, and 5 to include reconciliation and repayment amounts; revises beneficiary inclusion criteria; adopts changes to the reconciliation process; clarifies determinations that may be appealed; streamlines beneficiary notification requirements; expands the permissible types of CJR collaborators; revises SNF waiver policies; adds to the list of permissible CJR collaborators; and modifies the terms for CJR sharing arrangements.

Medicare ACO Track 1+ Model

Separate from the final rule, CMS announced a new Medicare ACO Track 1+ Model incorporating more limited downside risk than in Tracks 2 or 3 of the Medicare Shared Savings Program. This model, which will begin in 2018, will qualify as an Advanced APM for purposes of the Quality Payment Program.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.